AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 1.390
+0.005 (0.36%)
May 21, 2026, 12:23 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 159.16 million as of May 21, 2026. Its market cap has decreased by -23.94% in one year.
Market Cap
159.16M
Enterprise Value
128.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.39
Market Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 415.42M to 159.16M, a decrease of -61.69%. That is a compound annual growth rate of -12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 159.16M | -30.75% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 226.66M |
| Xintela AB | 212.73M |
| Initiator Pharma | 200.57M |
| Active Biotech AB | 197.18M |
| Diamyd Medical AB | 185.36M |
| Nanologica AB | 161.43M |
| Elicera Therapeutics AB | 145.12M |
| Simris Group AB (PUBL) | 144.43M |